These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23932157)

  • 1. Quality of life among prostate cancer patients: a prospective longitudinal population-based study.
    Schaake W; de Groot M; Krijnen WP; Langendijk JA; van den Bergh AC
    Radiother Oncol; 2013 Aug; 108(2):299-305. PubMed ID: 23932157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
    Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
    J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
    Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
    Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls.
    Fransson P
    Acta Oncol; 2008; 47(5):852-61. PubMed ID: 17899451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.
    Christie D; Denham J; Steigler A; Lamb D; Turner S; Mameghan H; Joseph D; Matthews J; Franklin I; Atkinson C; North J; Poulsen M; Spry NA; Tai KH; Wynne C; Duchesne G; Kovacev O; Francis L; Kramar A; D'Este C; Bill D
    Radiother Oncol; 2005 Nov; 77(2):117-25. PubMed ID: 16271786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
    J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy.
    Hashine K; Azuma K; Koizumi T; Sumiyoshi Y
    Int J Clin Oncol; 2005 Feb; 10(1):45-50. PubMed ID: 15729601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy.
    Komiya A; Fujiuchi Y; Ito T; Morii A; Yasuda K; Watanabe A; Nozaki T; Iida H; Nomura K; Fuse H
    Int J Urol; 2013 Feb; 20(2):185-92. PubMed ID: 22905941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer.
    Geinitz H; Thamm R; Scholz C; Heinrich C; Prause N; Kerndl S; Keller M; Busch R; Molls M; Zimmermann FB
    Strahlenther Onkol; 2010 Jan; 186(1):46-52. PubMed ID: 20082188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
    Coen JJ; Paly JJ; Niemierko A; Weyman E; Rodrigues A; Shipley WU; Zietman AL; Talcott JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e201-9. PubMed ID: 21621343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer.
    Fransson P
    Acta Oncol; 2005; 44(4):355-61. PubMed ID: 16120544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.